ctDNA
Showing 1 - 25 of 1,216
Metastatic Colorectal Cancer, No Evidence of Disease Status, ctDNA Monitoring Trial in Shanghai (ctDNA and adjuvant therapy,
Recruiting
- Metastatic Colorectal Cancer
- +2 more
- ctDNA and adjuvant therapy
- ctDNA
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 22, 2022
ctDNA Predicts Recurrence of Advanced Ovarian Cancer After
Recruiting
- Ovarian Cancer Stage IV
- Ovarian Cancer Stage III
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital
Aug 30, 2023
ctDNA in Resectable and Borderline Resectable Pancreatic Cancer
Recruiting
- Pancreatic Cancer
- SIGNATERA™ ctDNA testing
-
Fairfax, VirginiaInova Schar Cancer Institute
Oct 26, 2022
ctDNA Testing Plus AI-based Pathology in Resectable LSCC
Recruiting
- Lung Squamous Cell Carcinoma
- WES and ctDNA detection
-
Changsha, Hunan, ChinaDepartment of Thoracic Surgery, Second Xiangya Hospital of Centr
Mar 18, 2023
Chemoresistance Mechanisms in Pancreatic Cancer
Not yet recruiting
- Patients With Non-metastatic Pancreatic Cancer
- Evaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma
- ctDNA detection
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Apr 27, 2023
Ovarian Cancer Trial in Roma (Blood samples)
Not yet recruiting
- Ovarian Cancer
- Blood samples
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 3, 2023
Appendiceal Adenocarcinoma, Colorectal Trial in Houston (Circulating tumoral DNA directed neoadjuvant therapy arm)
Not yet recruiting
- Appendiceal Adenocarcinoma
- Colorectal
- Circulating tumoral DNA directed neoadjuvant therapy arm
-
Houston, TexasM D Anderson Cancer Center
Jul 7, 2023
Older Women With ER+ Breast Cancer Who Omit Surgery
Recruiting
- Breast Cancer
-
Pittsburgh, PennsylvaniaUPMC Magee Womens Hospital - Surgical Oncology
Jun 13, 2023
ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction
Not yet recruiting
- Non-small Cell Lung Cancer
- NGS and ctDNA-MRD detection
-
Changsha, Hunan, ChinaDepartment of Thoracic Surgery, Second Xiangya Hospital of Centr
Apr 18, 2023
Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou
Not yet recruiting
- Minimal Residual Disease
- Esophageal Squamous Cell Carcinoma
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Jun 10, 2023
Postoperative Recurrence in Biliary Tract Cancers:A Multicenter
Recruiting
- Biliary Tract Cancer
- No intervention
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with NanJing Medical University
Feb 15, 2023
Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
Active, not recruiting
- Melanoma
-
Murray, Utah
- +1 more
Feb 17, 2023
Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
Recruiting
- Esophageal Squamous Cell Carcinoma
-
Shijiazhuang, Hebei, ChinaDepartment of Thoracic Surgery, Fourth Hospital of Hebei Medical
Oct 25, 2023
Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma
Recruiting
- Pediatric Soft Tissue Sarcoma
- detection and monitoring of cirulating tumor DNA
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 20, 2023
ctDNA-MRD in Predicting Efficacy of Esophageal Squamous Cell
Not yet recruiting
- Squamous Cell Carcinoma of Esophagus
- (no location specified)
Feb 25, 2023
Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing
Recruiting
- Carcinoma
- +4 more
-
Nanjing, Jiangsu, ChinaJinling Hospital, Affiliated Hospital of Medical School, Nanjing
Jun 30, 2023
Pancreatic Cancer, Advanced Cancer, Metastatic Cancer Trial in Beijing (Later-line therapy)
Recruiting
- Pancreatic Cancer
- +2 more
- Later-line therapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Apr 10, 2023
ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.
Recruiting
- Breast Cancer Female
- +4 more
-
Ho Chi Minh City, Vietnam
- +1 more
Oct 16, 2023
Non Small Cell Lung Cancer Trial in Seoul (Lazertinib+Pemetrexed+Carboplatin, Lazertinib)
Not yet recruiting
- Non Small Cell Lung Cancer
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Aug 31, 2023
Gastrointestinal Stromal Tumors Trial in Miami (Sunitinib, Regorafenib)
Recruiting
- Gastrointestinal Stromal Tumors
-
Miami, FloridaUniversity of Miami
Jan 3, 2023
ctDNA Methylation for Epithelial Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- +7 more
- CDO1 and HOXA9 methylation assay
-
Beijing, Beijing, ChinaLei Li
Mar 24, 2023
ctDNA in Muscle-invasive Bladder Cancer Treated With Trimodality
Recruiting
- Bladder Cancer
- Muscle-Invasive Bladder Carcinoma
-
Chapel Hill, North CarolinaNorth Carolina Cancer Hospital (UNC)
Jan 11, 2023
Pancreatic Cancer, Resectable Carcinoma Trial in Beijing (Later-line therapy)
Recruiting
- Pancreatic Cancer
- Resectable Carcinoma
- Later-line therapy
-
Beijing, ChinaDepartment of Medical Oncology, Peking Union Medical College Hos
Apr 10, 2023
Patient Decision Making in Early Stage Breast Cancer:Conjoint
Recruiting
- Triple Negative Breast Cancer
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Feb 14, 2023